definiens: shall mean ( I ) a generic version of the Royalty Product approved by the FDA under an Abbreviated New Drug Application ( ) or any equivalent approval by a regulatory authority in as may be available at the time in the U.S. or the applicable country, or ( m a product consisting of, containing or comprising ( a ) other enantiomeric forms of the compounds contained in the Royalty Product, ( b ) other salt forms of the compound contained in the Royalty Product, or ( c ) a pro - drug that is metabolized to the same active moiety as the compound contained in the Royalty Product . For purposes of the 11 foregoing analysis, the market share of the Competitor Products shall be calculated in accordance with the formula AlA + B, where represents the number of units of the Competitor Products sold in the applicable country and represents the number of units of the Royalty Product sold in the applicable country . Data regarding the number of units shall be obtained from a mutually­acceptable company using a mutually - acceptable research methodology, such as IMS Health Data Corp. or some other comparable entity